Setting

APAC CRISPR Gene Editing Market 2021-2031 by Offering (Products, Services), Application (Biomedical, Agriculture, Industrial, Others), End User (Pharmaceutical Companies, Biotechnology Companies, Academic Institutions & Research Centers, Others), and Country: Trend Forecast and Growth Opportunity

Published: 28 Feb 2022 | Report Code: 10248403 | Pages: 126

Asia Pacific CRISPR Gene Editing market will grow by 28.6% annually with a total addressable market cap of $21.45 billion over 2022-2031, driven by the rising demand for better food and medical products, innovative advancement in gene therapy supported by the continued investments in healthcare, rising geriatric population and the increasing genomic and chronic diseases, and the development of rapid CRISPR-based POC tests amid COVID-19 pandemic. Highlighted with 35 tables and 53 figures, this 126-page report “Asia Pacific CRISPR Gene Editing Market 2021-2031 by Offering (Products, Services), Application (Biomedical, Agriculture, Industrial, Others), End User (Pharmaceutical Companies, Biotechnology Companies, Academic Institutions & Research Centers, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific CRISPR Gene Editing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific CRISPR Gene Editing market in every aspect of the classification from perspectives of Offering, Application, End User, and Country. Based on Offering, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • CRISPR Products o Kits & Enzymes ? Vector-Based Cas9 ? DNA-Free Cas9 o Databases & Libraries o Design Tools o Antibodies o CRISPR Plasmid & Vector o Other Products • CRISPR Services o gRNA Design & Vector Construction o Cell Line Engineering o Microbial Gene Editing o DNA Synthesis o Other Services Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Biomedical Research & Therapy o Gene Therapy o Drug Discovery o Diagnostics o Other Biomedical Applications • Agriculture • Industrial Use • Other Applications By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Pharmaceutical Companies • Biotechnology Companies • Academic Institutions & Research Centers • Other End Users Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of key national markets by Offering, Application, and End User, over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abcam, Inc. Agilent Technologies, Inc. Applied StemCell, Inc. Caribou Biosciences, Inc. Cellecta, Inc. CRISPR Therapeutics AG Editas Medicine, Inc. GeneCopoeia, Inc. GeneScript Biotech Corporation Horizon Discovery Group PLC Integrated DNA Technologies, Inc. Intellia Therapeutics Inc. Lonza Group Ltd. Merck KGaA New England Biolabs, Inc. Origene Technologies, Inc. Rockland Immunochemicals, Inc. Synthego Corporation System Biosciences LLC Takara Bio, Inc. Thermo Fisher Scientific, Inc. ToolGen, Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

1 Introduction	7
1.1 Industry Definition and Research Scope	7
1.1.1 Industry Definition	7
1.1.2 Research Scope	9
1.2 Research Methodology	12
1.2.1 Overview of Market Research Methodology	12
1.2.2 Market Assumption	13
1.2.3 Secondary Data	13
1.2.4 Primary Data	13
1.2.5 Data Filtration and Model Design	14
1.2.6 Market Size/Share Estimation	15
1.2.7 Research Limitations	16
1.3 Executive Summary	17
2 Market Overview and Dynamics	20
2.1 Market Size and Forecast	20
2.1.1 Impact of COVID-19 on World Economy	23
2.1.2 Impact of COVID-19 on the Market	25
2.2 Major Growth Drivers	27
2.3 Market Restraints and Challenges	36
2.4 Emerging Opportunities and Market Trends	39
2.5 Porter’s Fiver Forces Analysis	43
3 Segmentation of Asia Pacific Market by Offering	47
3.1 Market Overview by Offering	47
3.2 CRISPR Products	49
3.2.1 Kits & Enzymes	51
3.2.2 Databases & Libraries	52
3.2.3 Design Tools	53
3.2.4 Antibodies	54
3.2.5 CRISPR Plasmid & Vector	55
3.2.6 Other Products	56
3.3 CRISPR Services	57
3.3.1 gRNA Design & Vector Construction	59
3.3.2 Cell Line Engineering	60
3.3.3 Microbial Gene Editing	61
3.3.4 DNA Synthesis	62
3.3.5 Other Services	63
4 Segmentation of Asia Pacific Market by Application	64
4.1 Market Overview by Application	64
4.2 Biomedical Research & Therapy	66
4.2.1 Gene Therapy	68
4.2.2 Drug Discovery	69
4.2.3 Diagnostics	70
4.2.4 Other Biomedical Applications	71
4.3 Agriculture	72
4.4 Industrial Use	73
4.5 Other Applications	74
5 Segmentation of Asia Pacific Market by End User	75
5.1 Market Overview by End User	75
5.2 Pharmaceutical Companies	77
5.3 Biotechnology Companies	78
5.4 Academic Institutions & Research Centers	79
5.5 Other End Users	80
6 Asia-Pacific Market 2021-2031 by Country	81
6.1 Overview of Asia-Pacific Market	81
6.2 Japan	84
6.3 China	87
6.4 Australia	89
6.5 India	92
6.6 South Korea	94
6.7 Rest of APAC Region	96
7 Competitive Landscape	98
7.1 Overview of Key Vendors	98
7.2 New Product Launch, Partnership, Investment, and M&A	102
7.3 Company Profiles	103
Abcam, Inc.	103
Agilent Technologies, Inc.	105
Applied StemCell, Inc.	106
Caribou Biosciences, Inc.	107
Cellecta, Inc.	108
CRISPR Therapeutics AG	109
Editas Medicine, Inc.	110
GeneCopoeia, Inc.	111
GeneScript Biotech Corporation	112
Horizon Discovery Group PLC	113
Integrated DNA Technologies, Inc.	114
Intellia Therapeutics Inc.	115
Lonza Group Ltd.	116
Merck KGaA	117
New England Biolabs, Inc.	118
Origene Technologies, Inc.	119
Rockland Immunochemicals, Inc.	120
Synthego Corporation	121
System Biosciences LLC	122
Takara Bio, Inc.	123
Thermo Fisher Scientific, Inc.	124
ToolGen, Inc.	125
RELATED REPORTS	126
List Of Tables:


Table 1.  Snapshot of Asia Pacific CRISPR Gene Editing Market in Balanced Perspective, 2021-2031	18
Table 2. World Economic Outlook, 2021-2031	24
Table 3. Developing Roadmap of CRISPR Technology	28
Table 4. Private and Public Companies Investment in CRISPR Technology	29
Table 5. Comparison of CRISPR with Other Gene Editing Technologies	32
Table 6. World Health Spending by Region, $ bn, 2013-2020	35
Table 7.  Main Product Trends and Market Opportunities in Asia Pacific CRISPR Gene Editing Market	39
Table 8. Asia Pacific CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	47
Table 9. Asia Pacific CRISPR Gene Editing Market: CRISPR Products by Type, 2021-2031, $ mn	50
Table 10. Asia Pacific CRISPR Gene Editing Market: Kits & Enzymes by Type, 2021-2031, $ mn	51
Table 11. Asia Pacific CRISPR Gene Editing Market: CRISPR Services by Type, 2021-2031, $ mn	58
Table 12. Asia Pacific CRISPR Gene Editing Market by Application, 2021-2031, $ mn	64
Table 13. Asia Pacific CRISPR Gene Editing Market: Biomedical Research & Therapy by Type, 2021-2031, $ mn	67
Table 14. Asia Pacific CRISPR Gene Editing Market by End User, 2021-2031, $ mn	75
Table 15. APAC CRISPR Gene Editing Market by Country, 2021-2031, $ mn	82
Table 16. Japan CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	86
Table 17. Japan CRISPR Gene Editing Market by Application, 2021-2031, $ mn	86
Table 18. Japan CRISPR Gene Editing Market by End User, 2021-2031, $ mn	86
Table 19. China CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	88
Table 20. China CRISPR Gene Editing Market by Application, 2021-2031, $ mn	88
Table 21. China CRISPR Gene Editing Market by End User, 2021-2031, $ mn	88
Table 22. Australia CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	91
Table 23. Australia CRISPR Gene Editing Market by Application, 2021-2031, $ mn	91
Table 24. Australia CRISPR Gene Editing Market by End User, 2021-2031, $ mn	91
Table 25. India CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	93
Table 26. India CRISPR Gene Editing Market by Application, 2021-2031, $ mn	93
Table 27. India CRISPR Gene Editing Market by End User, 2021-2031, $ mn	93
Table 28. South Korea CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	95
Table 29. South Korea CRISPR Gene Editing Market by Application, 2021-2031, $ mn	95
Table 30. South Korea CRISPR Gene Editing Market by End User, 2021-2031, $ mn	95
Table 31. CRISPR Gene Editing Market in Rest of APAC by Country/Region, 2021-2031, $ mn	97
Table 32. Breakdown of World Market by Key Vendor, 2021, %	100
Table 33. Abcam, Inc.: Company Snapshot	103
Table 34. Abcam, Inc.: Business Segmentation	104
Table 35. Abcam, Inc.: Product Portfolio	104
List Of Figures:


Figure 1. Research Method Flow Chart	12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	15
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031	17
Figure 4. Asia Pacific CRISPR Gene Editing Market, 2021-2031, $ mn	20
Figure 5. Categories of CRISPR-Cas Systems	21
Figure 6. Impact of COVID-19 on Business	25
Figure 7. Primary Drivers and Impact Factors of Asia Pacific CRISPR Gene Editing Market	27
Figure 8.  Leading Causes of Death in the World, 2019-2020, million	33
Figure 9.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	34
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060	34
Figure 11. Primary Restraints and Impact Factors of Asia Pacific CRISPR Gene Editing Market	36
Figure 12. Investment Opportunity Analysis	40
Figure 13. Porter’s Fiver Forces Analysis of Asia Pacific CRISPR Gene Editing Market	43
Figure 14. Breakdown of Asia Pacific CRISPR Gene Editing Market by Offering, 2021-2031, % of Revenue	48
Figure 15. Asia Pacific Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%)	48
Figure 16. Asia Pacific CRISPR Gene Editing Market by Offering: CRISPR Products, 2021-2031, $ mn	49
Figure 17. Asia Pacific CRISPR Gene Editing Market by CRISPR Products: Kits & Enzymes, 2021-2031, $ mn	51
Figure 18. Asia Pacific CRISPR Gene Editing Market by CRISPR Products: Databases & Libraries, 2021-2031, $ mn	52
Figure 19. Asia Pacific CRISPR Gene Editing Market by CRISPR Products: Design Tools, 2021-2031, $ mn	53
Figure 20. Asia Pacific CRISPR Gene Editing Market by CRISPR Products: Antibodies, 2021-2031, $ mn	54
Figure 21. Asia Pacific CRISPR Gene Editing Market by CRISPR Products: CRISPR Plasmid & Vector, 2021-2031, $ mn	55
Figure 22. Asia Pacific CRISPR Gene Editing Market by CRISPR Products: Other Products, 2021-2031, $ mn	56
Figure 23. Asia Pacific CRISPR Gene Editing Market by Offering: CRISPR Services, 2021-2031, $ mn	57
Figure 24. Asia Pacific CRISPR Gene Editing Market by CRISPR Services: gRNA Design & Vector Construction, 2021-2031, $ mn	59
Figure 25. Asia Pacific CRISPR Gene Editing Market by CRISPR Services: Cell Line Engineering, 2021-2031, $ mn	60
Figure 26. Asia Pacific CRISPR Gene Editing Market by CRISPR Services: Microbial Gene Editing, 2021-2031, $ mn	61
Figure 27. Asia Pacific CRISPR Gene Editing Market by CRISPR Services: DNA Synthesis, 2021-2031, $ mn	62
Figure 28. Asia Pacific CRISPR Gene Editing Market by CRISPR Services: Other Services, 2021-2031, $ mn	63
Figure 29. Breakdown of Asia Pacific CRISPR Gene Editing Market by Application, 2021-2031, % of Sales Revenue	65
Figure 30. Asia Pacific Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)	65
Figure 31. Asia Pacific CRISPR Gene Editing Market by Application: Biomedical Research & Therapy, 2021-2031, $ mn	66
Figure 32. Asia Pacific CRISPR Gene Editing Market by Biomedical Research & Therapy: Gene Therapy, 2021-2031, $ mn	68
Figure 33. Asia Pacific CRISPR Gene Editing Market by Biomedical Research & Therapy: Drug Discovery, 2021-2031, $ mn	69
Figure 34. Asia Pacific CRISPR Gene Editing Market by Biomedical Research & Therapy: Diagnostics, 2021-2031, $ mn	70
Figure 35. Asia Pacific CRISPR Gene Editing Market by Biomedical Research & Therapy: Other Biomedical Applications, 2021-2031, $ mn	71
Figure 36. Asia Pacific CRISPR Gene Editing Market by Application: Agriculture, 2021-2031, $ mn	72
Figure 37. Asia Pacific CRISPR Gene Editing Market by Application: Industrial Use, 2021-2031, $ mn	73
Figure 38. Asia Pacific CRISPR Gene Editing Market by Application: Other Applications, 2021-2031, $ mn	74
Figure 39. Breakdown of Asia Pacific CRISPR Gene Editing Market by End User, 2021-2031, % of Sales Revenue	76
Figure 40. Asia Pacific Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)	76
Figure 41. Asia Pacific CRISPR Gene Editing Market by End User: Pharmaceutical Companies, 2021-2031, $ mn	77
Figure 42. Asia Pacific CRISPR Gene Editing Market by End User: Biotechnology Companies, 2021-2031, $ mn	78
Figure 43. Asia Pacific CRISPR Gene Editing Market by End User: Academic Institutions & Research Centers, 2021-2031, $ mn	79
Figure 44. Asia Pacific CRISPR Gene Editing Market by End User: Other End Users, 2021-2031, $ mn	80
Figure 45. Breakdown of APAC CRISPR Gene Editing Market by Country, 2021 and 2031, % of Revenue	82
Figure 46. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	83
Figure 47.  CRISPR Gene Editing Market in Japan, 2021-2031, $ mn	85
Figure 48.  CRISPR Gene Editing Market in China, 2021-2031, $ mn	87
Figure 49.  CRISPR Gene Editing Market in Australia, 2021-2031, $ mn	89
Figure 50.  CRISPR Gene Editing Market in India, 2021-2031, $ mn	92
Figure 51.  CRISPR Gene Editing Market in South Korea, 2021-2031, $ mn	94
Figure 52.  CRISPR Gene Editing Market in Rest of APAC, 2021-2031, $ mn	96
Figure 53. Growth Stage of Asia Pacific CRISPR Gene Editing Industry over the Forecast Period	98
Selected Key Players: 
Abcam, Inc.
Agilent Technologies, Inc.
Applied StemCell, Inc.
Caribou Biosciences, Inc.
Cellecta, Inc.
CRISPR Therapeutics AG
Editas Medicine, Inc.
GeneCopoeia, Inc.
GeneScript Biotech Corporation
Horizon Discovery Group PLC
Integrated DNA Technologies, Inc.
Intellia Therapeutics Inc.
Lonza Group Ltd.
Merck KGaA
New England Biolabs, Inc.
Origene Technologies, Inc.
Rockland Immunochemicals, Inc.
Synthego Corporation
System Biosciences LLC
Takara Bio, Inc.
Thermo Fisher Scientific, Inc.
ToolGen, Inc. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)